Literature DB >> 17972040

Plasma homocysteine and severe white matter disease.

B Censori1, T Partziguian, O Manara, M Poloni.   

Abstract

The objective of this study was to assess if high total plasma homocysteine (tHcy) levels are a risk factor for severe leukoaraiosis (LA). This case-control study was done in a primary care neurology ward and included 178 consecutive patients. Patients with severe LA at CT scan were compared with patients without any LA regarding age, cerebrovascular risk factors, tHcy, vitamin B12, folate, creatinine levels and dementia. Multivariate logistic regression was used to find variables independently associated with severe LA. Age (odds ratio [OR], 1.10 per year; p<0.0001), tHcy (OR, 1.07/micromol/l increase; p=0.045) and hypertension (OR, 2.97; p=0.007) were significantly associated with severe LA. Total homocysteine levels are associated with severe LA independently of other risk factors for cerebrovascular disease. This may suggest that decreasing tHcy may help preserve the integrity of the brain white matter.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17972040     DOI: 10.1007/s10072-007-0832-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  30 in total

1.  Changes in plasma homocyst(e)ine in the acute phase after stroke.

Authors:  Virginia J Howard; Elizabeth G Sides; George C Newman; Stanley N Cohen; George Howard; M Rene Malinow; James F Toole
Journal:  Stroke       Date:  2002-02       Impact factor: 7.914

2.  Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.

Authors:  J W Eikelboom; G J Hankey; S S Anand; E Lofthouse; N Staples; R I Baker
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

3.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

4.  Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study.

Authors:  R Schmidt; F Fazekas; M Hayn; H Schmidt; P Kapeller; G Roob; H Offenbacher; M Schumacher; B Eber; V Weinrauch; G M Kostner; H Esterbauer
Journal:  J Neurol Sci       Date:  1997-11-06       Impact factor: 3.181

5.  Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study.

Authors:  Clinton B Wright; Myunghee C Paik; Truman R Brown; Sally P Stabler; Robert H Allen; Ralph L Sacco; Charles DeCarli
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

Review 6.  Homocysteine and stroke.

Authors:  G J Hankey; J W Eikelboom
Journal:  Curr Opin Neurol       Date:  2001-02       Impact factor: 5.710

7.  Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study.

Authors:  W T Longstreth; Ronit Katz; Jean Olson; Charles Bernick; J Jeffrey Carr; M René Malinow; David L Hess; Mary Cushman; Stephen M Schwartz
Journal:  Arch Neurol       Date:  2004-01

8.  Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.

Authors:  Rita Castro; Isabel Rivera; Eduard A Struys; Erwin E W Jansen; Paula Ravasco; Maria Ermelinda Camilo; Henk J Blom; Cornelis Jakobs; Isabel Tavares de Almeida
Journal:  Clin Chem       Date:  2003-08       Impact factor: 8.327

9.  Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial.

Authors:  James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

10.  Homocysteine and the brain in midadult life: evidence for an increased risk of leukoaraiosis in men.

Authors:  Perminder Sachdev; Ruth Parslow; Chris Salonikas; Ora Lux; Wei Wen; Rajeev Kumar; Daya Naidoo; Helen Christensen; Anthony Jorm
Journal:  Arch Neurol       Date:  2004-09
View more
  11 in total

1.  Homocysteine and leukoaraiosis: time for a clinical trial?

Authors:  S Sacco; A Carolei
Journal:  Neurol Sci       Date:  2007-10       Impact factor: 3.307

2.  Evaluation of the MTHFR A1298C variant in leukoaraiosis.

Authors:  Zoltan Szolnoki; Istvan Szaniszlo; Marta Szekeres; Krisztina Hitri; Andras Kondacs; Yvette Mandi; Erika Nedo; Ferenc Somogyvari
Journal:  J Mol Neurosci       Date:  2011-08-16       Impact factor: 3.444

3.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

4.  Synergistic effects of the MTHFR C677T polymorphism and hypertension on spatial navigation.

Authors:  Awantika Deshmukh; Karen M Rodrigue; Kristen M Kennedy; Susan Land; Bradley S Jacobs; Naftali Raz
Journal:  Biol Psychol       Date:  2008-11-01       Impact factor: 3.251

5.  Low vitamin and carotenoid levels are related to cerebral white matter lesions.

Authors:  Y Ohshima; T Mizuno; K Yamada; S Matsumoto; Y Nagakane; M Kondo; N Kuriyama; T Miyazaki; K Takeda; T Nishimura; M Nakagawa; K Ozasa; Y Watanabe
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

6.  Risk of dementia associated with elevated plasma homocysteine in a latin american population.

Authors:  Inara J Chacón; Aldrín E Molero; Gloria Pino-Ramírez; José A Luchsinger; Joseph H Lee; Gladys E Maestre
Journal:  Int J Alzheimers Dis       Date:  2009-08-23

7.  Age-related white matter changes.

Authors:  Yun Yun Xiong; Vincent Mok
Journal:  J Aging Res       Date:  2011-08-23

8.  Vitamin D, Folate, and Cobalamin Serum Concentrations Are Related to Brain Volume and White Matter Integrity in Urban Adults.

Authors:  May A Beydoun; Danielle Shaked; Sharmin Hossain; Hind A Beydoun; Leslie I Katzel; Christos Davatzikos; Rao P Gullapalli; Stephen L Seliger; Guray Erus; Michele K Evans; Alan B Zonderman; Shari R Waldstein
Journal:  Front Aging Neurosci       Date:  2020-05-25       Impact factor: 5.750

9.  Hyperhomocysteinemia associates with small vessel disease more closely than large vessel disease.

Authors:  Chao Feng; Xue Bai; Yu Xu; Ting Hua; Jing Huang; Xue-Yuan Liu
Journal:  Int J Med Sci       Date:  2013-02-28       Impact factor: 3.738

10.  Differential Impact of Plasma Homocysteine Levels on the Periventricular and Subcortical White Matter Hyperintensities on the Brain.

Authors:  Kee Ook Lee; Min-Hee Woo; Darda Chung; Jung-Won Choi; Nam-Keun Kim; Ok-Joon Kim; Seung-Hun Oh
Journal:  Front Neurol       Date:  2019-11-07       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.